FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18559811000001102: Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Apr 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63774401000001111 Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
63774501000001110 Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Is a Sumatriptan 50mg tablets 12 tablet true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Has AMP Sumatriptan 50mg tablets (Bristol Laboratories Ltd) true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Has specific active ingredient Sumatriptan succinate true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sumatriptan true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Sumatriptan 50mg tablets (Bristol Laboratories Ltd) 12 tablet Has basis of strength substance Sumatriptan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start